{"title":"芬戈莫德治疗多发性硬化症","authors":"Evelyn Joy","doi":"10.35248/2376-0389.21.8.241","DOIUrl":null,"url":null,"abstract":"Fingolimod (FTY720) is a sphingosine-1-phosphate-receptor modulator that Is administered orally, which is currently being evaluated for the multiple sclerosis treatment.","PeriodicalId":16369,"journal":{"name":"Journal of multiple sclerosis","volume":"509 1","pages":"1-1"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Fingolimod and its Treatment in Multiple Sclerosis\",\"authors\":\"Evelyn Joy\",\"doi\":\"10.35248/2376-0389.21.8.241\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Fingolimod (FTY720) is a sphingosine-1-phosphate-receptor modulator that Is administered orally, which is currently being evaluated for the multiple sclerosis treatment.\",\"PeriodicalId\":16369,\"journal\":{\"name\":\"Journal of multiple sclerosis\",\"volume\":\"509 1\",\"pages\":\"1-1\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of multiple sclerosis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35248/2376-0389.21.8.241\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of multiple sclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2376-0389.21.8.241","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Fingolimod and its Treatment in Multiple Sclerosis
Fingolimod (FTY720) is a sphingosine-1-phosphate-receptor modulator that Is administered orally, which is currently being evaluated for the multiple sclerosis treatment.